Dr. Reddy’s names North American generics head
Dr. Reddy’s has a new leader for its North American generics business. The company has named Marc Kikuchi CEO, North America generics. He will be based in Princeton, N.J.
“Dr. Reddy’s is a great company with a wide portfolio and remarkable heritage. I am excited to join Dr. Reddy’s and look forward to leveraging my past experiences to steer the company’s new growth areas,” Kikuchi said.
Kikuchi has over 20 years of experience in the pharmaceutical industry with extensive knowledge and understanding of generics, the company said.
He joins Dr. Reddy’s from Zydus Pharmaceuticals where he served as CEO, Americas since 2016. Prior to joining Zydus, he held professional leadership roles of increasing responsibility with AmerisourceBergen Corporation, Medrad, PRTM, Johnson & Johnson and Incyte Pharmaceuticals.
Kikuchi has a Bachelor’s Degree in molecular and cell biology with a biochemistry emphasis from the University of California at Berkeley and a master of business administration from Carnegie Mellon University in strategy, marketing, and operations management.
No comments found